Eva Gonzalez-Barca

11PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 26, 2025
Asparaginase Hypersensitivity Reactions in NK/T-Cell Lymphomas.

Javier Varela Gonzalez-Aller, Pablo Nadal, Salome Cañizares

|Jul 16, 2025
Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO.

Antonio Gutierrez, Izaskun Zeberio, Francisco Javier Peñalver

|Apr 09, 2025
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential.

Miriam Verdú-Bou, Maria Joao Baptista, Marcelo Lima Ribeiro

|Aug 25, 2023
Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas.

M Peña, C Montané, A Paviglianiti

|Mar 07, 2023
Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets.

Eva Gonzalez Barca, Laura Tomás-Roca, Anna Esteve

Pageof 2